Copeland Capital Management LLC Has $90.51 Million Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT)

Copeland Capital Management LLC decreased its holdings in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 8.0% in the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,078,723 shares of the medical instruments supplier's stock after selling 93,292 shares during the period. LeMaitre Vascular accounts for 1.8% of Copeland Capital Management LLC's portfolio, making the stock its 7th largest position. Copeland Capital Management LLC owned approximately 4.78% of LeMaitre Vascular worth $90,505,000 as of its most recent SEC filing.

Several other large investors have also recently made changes to their positions in the business. Opal Wealth Advisors LLC bought a new position in shares of LeMaitre Vascular during the first quarter valued at $26,000. Smartleaf Asset Management LLC grew its position in LeMaitre Vascular by 234.4% during the 4th quarter. Smartleaf Asset Management LLC now owns 418 shares of the medical instruments supplier's stock valued at $39,000 after purchasing an additional 293 shares during the last quarter. CBIZ Investment Advisory Services LLC increased its stake in LeMaitre Vascular by 38.5% during the 4th quarter. CBIZ Investment Advisory Services LLC now owns 421 shares of the medical instruments supplier's stock valued at $39,000 after purchasing an additional 117 shares in the last quarter. NBC Securities Inc. purchased a new position in LeMaitre Vascular in the first quarter worth about $36,000. Finally, Huntington National Bank lifted its stake in shares of LeMaitre Vascular by 64.9% in the fourth quarter. Huntington National Bank now owns 1,156 shares of the medical instruments supplier's stock worth $107,000 after buying an additional 455 shares in the last quarter. 84.64% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other LeMaitre Vascular news, CEO George W. Lemaitre sold 76,868 shares of the company's stock in a transaction that occurred on Monday, May 19th. The stock was sold at an average price of $85.79, for a total value of $6,594,505.72. Following the completion of the transaction, the chief executive officer directly owned 1,796,783 shares in the company, valued at $154,146,013.57. This represents a 4.10% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Insiders have sold a total of 100,000 shares of company stock worth $8,556,857 over the last quarter. 9.50% of the stock is owned by insiders.

LeMaitre Vascular Stock Up 0.8%

Shares of NASDAQ:LMAT traded up $0.64 during trading on Tuesday, reaching $83.69. 108,025 shares of the stock traded hands, compared to its average volume of 169,647. The stock has a market cap of $1.89 billion, a P/E ratio of 42.27, a price-to-earnings-growth ratio of 2.18 and a beta of 0.83. The company has a debt-to-equity ratio of 0.48, a quick ratio of 13.83 and a current ratio of 16.49. The stock has a 50-day moving average of $83.63 and a two-hundred day moving average of $88.57. LeMaitre Vascular, Inc. has a 52-week low of $71.42 and a 52-week high of $109.58.

LeMaitre Vascular (NASDAQ:LMAT - Get Free Report) last issued its earnings results on Thursday, May 1st. The medical instruments supplier reported $0.48 EPS for the quarter, missing the consensus estimate of $0.50 by ($0.02). LeMaitre Vascular had a net margin of 19.96% and a return on equity of 13.53%. The business had revenue of $59.87 million for the quarter, compared to analysts' expectations of $57.61 million. During the same quarter in the prior year, the business posted $0.44 earnings per share. The business's revenue for the quarter was up 12.0% on a year-over-year basis. As a group, sell-side analysts expect that LeMaitre Vascular, Inc. will post 1.94 earnings per share for the current fiscal year.

LeMaitre Vascular Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Thursday, May 29th. Shareholders of record on Thursday, May 15th were paid a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a yield of 0.96%. The ex-dividend date of this dividend was Thursday, May 15th. LeMaitre Vascular's payout ratio is 40.40%.

About LeMaitre Vascular

LeMaitre Vascular, Inc develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature.